Differential Diagnosis of Flavivirus Infections in Horses Using Viral Envelope Protein Domain III Antigens in Enzyme-Linked Immunosorbent Assay by Piyasena, Thisun B.H. et al.
Differential Diagnosis of Flavivirus Infections
in Horses Using Viral Envelope Protein Domain III
Antigens in Enzyme-Linked Immunosorbent Assay
Thisun B.H. Piyasena,1,* Yin X. Setoh,1,* Jody Hobson-Peters,1 Natalie A. Prow,1 Helle Bielefeldt-Ohmann,1,2
Alexander A. Khromykh,1 David Perera,3 Mary J. Cardosa,3 Peter D. Kirkland,4 and Roy A. Hall1
Abstract
In Australia, infection of horses with the West Nile virus (WNV) or Murray Valley encephalitis virus (MVEV)
occasionally results in severe neurological disease that cannot be clinically differentiated. Confirmatory serological
tests to detect antibody specific for MVEV or WNV in horses are often hampered by cross-reactive antibodies
induced to conserved epitopes on the envelope (E) protein. This study utilized bacterially expressed recombinant
antigens derived from domain III of the E protein (rE-DIII) of MVEV and WNV, respectively, to determine
whether these subunit antigens provided specific diagnostic markers of infection with these two viruses. When a
panel of 130 serum samples, from horses with known flavivirus infection status, was tested in enzyme-linked
immunosorbent assay (ELISA) using rE-DIII antigens, a differential diagnosis of MVEV or WNV was achieved
for most samples. Time-point samples from horses exposed to flavivirus infection during the 2011 outbreak of
equine encephalitis in south-eastern Australia also indicated that the rE-DIII antigens were capable of detecting and
differentiating MVEV and WNV infection in convalescent sera with similar sensitivity and specificity to virus
neutralization tests and blocking ELISAs. Overall, these results indicate that the rE-DIII is a suitable antigen for use
in rapid immunoassays for confirming MVEV and WNV infections in horses in the Australian context and warrant
further assessment on sensitive, high-throughput serological platforms such as multiplex immune assays.
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Introduction
West Nile virus (WNV) and Murray Valley encepha-litis virus (MVEV) are mosquito-borne flaviviruses
that are endemic to the tropical north of Australia. Although
the Australian strain of WNV shares high antigenic similarity
with strains of WNV circulating in other parts of the world
(Hall 2000, Scherret et al. 2001), disease is infrequently ob-
served. MVEV is the leading cause of arboviral encephalitis
in humans in Australia (Mackenzie and Williams 2009,
Schweitzer et al. 2009, Knox et al. 2012) and infection with
either virus can produce equine disease with clinical symp-
toms such as ataxia, altered mental state, and encephalitis,
which can subsequently lead to permanent neurological se-
quelae or death (Roche et al. 2013, Barton et al. 2015).
MVEV and WNV activity is monitored in Australia by
sero-conversion in sentinel chickens and by virus isolation
from captured Culex annulirostris mosquitoes, which is the
main transmission vector for these viruses (Mackenzie et al.
1994, Bolisetty et al. 2002). Occasionally, these viruses
spread from their northern endemic foci to more southerly
regions during times of unusually high rainfall (Mackenzie
et al. 1994, Brown et al. 2002, Hall et al. 2002, Mackenzie
and Williams 2009).
In 2011, there was an outbreak of equine viral encephalitis
in south-eastern Australia with at least 1000 documented
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